Wai Chun Bio-Technology Limited (0660.HK)
HKD 0.07
(0.0%)
HKD 0.07
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | 14.89 Million HKD | -52.88% |
| 2021 | 31.6 Million HKD | 80.39% |
| 2020 | 17.52 Million HKD | -22.51% |
| 2019 | 22.61 Million HKD | 147.48% |
| 2018 | -47.62 Million HKD | -571.68% |
| 2017 | -7.09 Million HKD | 78.09% |
| 2016 | -32.35 Million HKD | -127.72% |
| 2015 | -14.21 Million HKD | -12.36% |
| 2014 | -12.64 Million HKD | 35.78% |
| 2013 | -19.69 Million HKD | -79.77% |
| 2012 | -10.95 Million HKD | -135.55% |
| 2011 | 30.8 Million HKD | 4.04% |
| 2010 | 29.61 Million HKD | 215.49% |
| 2009 | -25.64 Million HKD | 58.89% |
| 2008 | -62.37 Million HKD | 3.98% |
| 2007 | -64.95 Million HKD | -16.99% |
| 2006 | -55.52 Million HKD | 9.45% |
| 2005 | -61.31 Million HKD | -69.99% |
| 2004 | -36.07 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | 11.5 Million HKD | 137.89% |
| 2023 Q3 | 4.83 Million HKD | -68.36% |
| 2023 Q2 | 15.29 Million HKD | 127.51% |
| 2023 Q1 | 6.72 Million HKD | -31.65% |
| 2022 Q3 | 3.99 Million HKD | -89.23% |
| 2022 Q4 | 9.83 Million HKD | 145.92% |
| 2022 FY | - HKD | -52.88% |
| 2022 Q2 | 37.12 Million HKD | 0.0% |
| 2021 Q3 | -2.21 Million HKD | -115.34% |
| 2021 Q4 | -2.29 Million HKD | -3.72% |
| 2021 FY | - HKD | 80.39% |
| 2021 Q1 | 6.04 Million HKD | 143.73% |
| 2021 Q2 | 14.44 Million HKD | 138.83% |
| 2020 Q3 | 2.72 Million HKD | -79.89% |
| 2020 Q1 | 6.81 Million HKD | -60.37% |
| 2020 Q4 | 2.48 Million HKD | -8.83% |
| 2020 Q2 | 13.54 Million HKD | 98.78% |
| 2020 FY | - HKD | -22.51% |
| 2019 Q2 | 1.77 Million HKD | 85.96% |
| 2019 Q3 | 9.26 Million HKD | 422.03% |
| 2019 Q4 | 17.18 Million HKD | 85.5% |
| 2019 Q1 | 954.5 Thousand HKD | 104.33% |
| 2019 FY | - HKD | 147.48% |
| 2018 Q1 | -535.5 Thousand HKD | 88.38% |
| 2018 Q3 | -22.04 Million HKD | -4017.37% |
| 2018 FY | - HKD | -571.68% |
| 2018 Q4 | -22.04 Million HKD | 0.0% |
| 2018 Q2 | -535.5 Thousand HKD | 0.0% |
| 2017 Q4 | -4.6 Million HKD | 0.0% |
| 2017 Q3 | -4.6 Million HKD | -329.39% |
| 2017 Q2 | -1.07 Million HKD | 0.0% |
| 2017 FY | - HKD | 78.09% |
| 2017 Q1 | -1.07 Million HKD | 50.23% |
| 2016 FY | - HKD | -127.72% |
| 2016 Q3 | -2.15 Million HKD | 85.68% |
| 2016 Q2 | -15.06 Million HKD | 0.0% |
| 2016 Q1 | -15.06 Million HKD | -181.81% |
| 2016 Q4 | -2.15 Million HKD | 0.0% |
| 2015 Q4 | -5.34 Million HKD | 0.0% |
| 2015 FY | - HKD | -12.36% |
| 2015 Q3 | -5.34 Million HKD | -55.63% |
| 2015 Q2 | -3.43 Million HKD | 0.0% |
| 2015 Q1 | -3.43 Million HKD | 14.25% |
| 2014 Q4 | -4 Million HKD | 0.0% |
| 2014 FY | - HKD | 35.78% |
| 2014 Q3 | -4 Million HKD | -59.09% |
| 2014 Q2 | -2.51 Million HKD | 0.0% |
| 2014 Q1 | -2.51 Million HKD | 53.21% |
| 2013 FY | - HKD | -79.77% |
| 2013 Q3 | -5.38 Million HKD | -11.93% |
| 2013 Q4 | -5.38 Million HKD | 0.0% |
| 2013 Q1 | -4.8 Million HKD | -51.62% |
| 2013 Q2 | -4.8 Million HKD | 0.0% |
| 2012 Q2 | -6.29 Million HKD | 0.0% |
| 2012 Q3 | -6.29 Million HKD | 0.0% |
| 2012 Q1 | -6.29 Million HKD | 0.0% |
| 2012 FY | - HKD | -135.55% |
| 2012 Q4 | -3.17 Million HKD | 49.61% |
| 2011 Q4 | -6.29 Million HKD | -289.8% |
| 2011 FY | - HKD | 4.04% |
| 2011 Q1 | 3.31 Million HKD | 0.0% |
| 2011 Q2 | 3.31 Million HKD | 0.0% |
| 2011 Q3 | 3.31 Million HKD | 0.0% |
| 2010 Q3 | 6.62 Million HKD | 0.0% |
| 2010 FY | - HKD | 215.49% |
| 2010 Q4 | 3.31 Million HKD | -49.97% |
| 2010 Q2 | 6.62 Million HKD | 0.0% |
| 2010 Q1 | 6.62 Million HKD | 0.0% |
| 2009 FY | - HKD | 58.89% |
| 2009 Q4 | 6.62 Million HKD | 231.03% |
| 2009 Q3 | -5.05 Million HKD | 0.0% |
| 2009 Q2 | -5.05 Million HKD | 0.0% |
| 2009 Q1 | -5.05 Million HKD | 0.0% |
| 2008 Q1 | -13.87 Million HKD | 0.0% |
| 2008 FY | - HKD | 3.98% |
| 2008 Q4 | -5.05 Million HKD | 63.53% |
| 2008 Q3 | -13.87 Million HKD | 0.0% |
| 2008 Q2 | -13.87 Million HKD | 0.0% |
| 2007 Q2 | -23.67 Million HKD | 0.0% |
| 2007 Q1 | -23.67 Million HKD | 0.0% |
| 2007 FY | - HKD | -16.99% |
| 2007 Q3 | -23.67 Million HKD | 0.0% |
| 2007 Q4 | -13.87 Million HKD | 41.42% |
| 2006 Q1 | -10.98 Million HKD | 0.0% |
| 2006 Q2 | -10.98 Million HKD | 0.0% |
| 2006 Q3 | -10.98 Million HKD | 0.0% |
| 2006 Q4 | -23.67 Million HKD | -115.55% |
| 2006 FY | - HKD | 9.45% |
| 2005 Q2 | -14.68 Million HKD | 0.0% |
| 2005 Q1 | -14.68 Million HKD | 0.0% |
| 2005 FY | - HKD | -69.99% |
| 2005 Q4 | -10.98 Million HKD | 25.19% |
| 2005 Q3 | -14.68 Million HKD | 0.0% |
| 2004 FY | - HKD | 0.0% |
| 2004 Q2 | -7.49 Million HKD | 0.0% |
| 2004 Q1 | -7.49 Million HKD | 0.0% |
| 2004 Q4 | -14.68 Million HKD | -95.94% |
| 2004 Q3 | -7.49 Million HKD | 0.0% |
| 2003 Q4 | -7.49 Million HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Lee & Man Chemical Company Limited | 597.01 Million HKD | 97.505% |